(Q37621552)

21 August 2017

1 reference

title

Antimicrobial susceptibility testing: a primer for clinicians (English)

1 reference

21 August 2017

Kristi M Kuper

1

1 reference

21 August 2017

Deborah M Boles

series ordinal

2

1 reference

21 August 2017

John F Mohr

series ordinal

3

1 reference

21 August 2017

Audrey Wanger

series ordinal

4

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

21 August 2017

1 reference

21 August 2017

29

1 reference

21 August 2017

11

1 reference

21 August 2017

1326-1343

1 reference

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

21 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci and enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Has antifungal susceptibility testing come of age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Setting and revising antibacterial susceptibility breakpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Use of a Heavy Inoculum in the In Vitro Evaluation of the Anti-Staphylococcal Activity of 19 Cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Pharmacokinetic/pharmacodynamic modeling can help guide targeted antimicrobial therapy for nosocomial gram-negative infections in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Pharmacodynamics of cefepime in patients with Gram-negative infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Validation of the Automated Reading and Incubation System with Sensititre Plates for Antimicrobial Susceptibility Testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Evaluation of the automated phoenix system for potential routine use in the clinical microbiology laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

A study of workload units in five microbiology laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

21 January 2018

Microbiology workload

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Antimicrobial susceptibility testing: special needs for fastidious organisms and difficult-to-detect resistance mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Detection of mecA-mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Performance of eight methods, including two new rapid methods, for detection of oxacillin resistance in a challenge set of Staphylococcus aureus organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Transcription of the gene mediating methicillin resistance in Staphylococcus aureus (mecA) is corepressed but not coinduced by cognate mecA and beta-lactamase regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Rapid differentiation of methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus from blood cultures by use of a direct cefoxitin disk diffusion test

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Failure of Clindamycin Treatment of Methicillin-Resistant Staphylococcus aureus Expressing Inducible Clindamycin Resistance In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Influence of disk separation distance on accuracy of the disk approximation test for detection of inducible clindamycin resistance in Staphylococcus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non-Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Plasmid-determined AmpC-type beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Evaluation of different laboratory tests for the detection of metallo-beta-lactamase production in Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1326

21 January 2018

Identifiers

DOI

10.1592/PHCO.29.11.1326

1 reference

21 August 2017

1 reference